The purpose of this study is to study resistance to current malaria treatments and affordable
alternatives for uncomplicated malaria. Resistance occurs in areas where these treatments are
used frequently. This study may help prevent future resistance. About 150 residents in
Buenaventura, Colombia will participate. They will have uncomplicated malaria and they will
be followed for 28 days after treatment. Physical exams and blood draws are included in study
visits.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)